Cymat Technologies Ltd. Logo

Cymat Technologies Ltd.

CYM.V

(0.2)
Stock Price

0,13 CAD

-107.69% ROA

234.78% ROE

-1.85x PER

Market Cap.

7.883.292,00 CAD

-74.35% DER

0% Yield

-263.42% NPM

Cymat Technologies Ltd. Stock Analysis

Cymat Technologies Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cymat Technologies Ltd. Fundamental Stock Analysis
# Analysis Rating
1 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

2 ROE

Negative ROE (-218.56%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-79.74%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (7.34x) suggests it's overvalued, potentially making it an expensive investment.

5 DER

The company has a high debt to equity ratio (157%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Cymat Technologies Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cymat Technologies Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Cymat Technologies Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cymat Technologies Ltd. Revenue
Year Revenue Growth
1997 2.128.281
1998 1.111.221 -91.53%
1999 776.833 -43.05%
2000 393.249 -97.54%
2001 0 0%
2002 246.603 100%
2003 340.525 27.58%
2004 397.688 14.37%
2005 547.015 27.3%
2006 2.166.715 74.75%
2007 2.946.701 26.47%
2008 1.006.497 -192.77%
2009 836.621 -20.31%
2010 1.852.632 54.84%
2011 2.795.444 33.73%
2012 925.515 -202.04%
2013 788.703 -17.35%
2014 1.609.120 50.99%
2015 1.354.841 -18.77%
2016 2.751.836 50.77%
2017 3.046.443 9.67%
2018 2.643.504 -15.24%
2019 1.687.208 -56.68%
2020 4.152.080 59.36%
2021 3.123.953 -32.91%
2022 3.053.346 -2.31%
2023 925.772 -229.82%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cymat Technologies Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
1997 225.250
1998 218.642 -3.02%
1999 1.041.923 79.02%
2000 2.134.833 51.19%
2001 5.999.022 64.41%
2002 7.240.333 17.14%
2003 4.713.546 -53.61%
2004 4.276.561 -10.22%
2005 4.042.671 -5.79%
2006 0 0%
2007 0 0%
2008 0 0%
2009 252.991 100%
2010 73.385 -244.74%
2011 20.722 -254.14%
2012 10.035 -106.5%
2013 8.028 -25%
2014 6.423 -24.99%
2015 5.138 -25.01%
2016 4.110 -25.01%
2017 80.695 94.91%
2018 196.261 58.88%
2019 143.450 -36.81%
2020 130.760 -9.7%
2021 181.477 27.95%
2022 183.718 1.22%
2023 157.432 -16.7%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cymat Technologies Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 4.572.005 100%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cymat Technologies Ltd. EBITDA
Year EBITDA Growth
1997 -328.994
1998 -1.046.040 68.55%
1999 -1.649.912 36.6%
2000 -3.561.187 53.67%
2001 -6.856.458 48.06%
2002 -8.334.636 17.74%
2003 -5.218.982 -59.7%
2004 -3.830.896 -36.23%
2005 -3.851.659 0.54%
2006 -3.093.798 -24.5%
2007 -2.647.405 -16.86%
2008 -3.002.377 11.82%
2009 -3.571.202 15.93%
2010 -2.496.955 -43.02%
2011 851.828 393.13%
2012 -1.241.498 168.61%
2013 -1.180.685 -5.15%
2014 -699.809 -68.72%
2015 -823.359 15.01%
2016 -175.828 -368.28%
2017 -691.673 74.58%
2018 -1.127.403 38.65%
2019 -1.511.984 25.44%
2020 230.689 755.42%
2021 -4.159.810 105.55%
2022 -5.052.526 17.67%
2023 -2.395.840 -110.89%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cymat Technologies Ltd. Gross Profit
Year Gross Profit Growth
1997 548.621
1998 381.995 -43.62%
1999 466.781 18.16%
2000 467.089 0.07%
2001 0 0%
2002 72.379 100%
2003 173.371 58.25%
2004 397.688 56.41%
2005 547.015 27.3%
2006 2.166.715 74.75%
2007 2.946.701 26.47%
2008 -388.493 858.5%
2009 -505.565 23.16%
2010 -1.067.104 52.62%
2011 -826.883 -29.05%
2012 -271.914 -204.1%
2013 -235.414 -15.5%
2014 367.573 164.05%
2015 189.969 -93.49%
2016 1.121.569 83.06%
2017 1.177.091 4.72%
2018 621.329 -89.45%
2019 373.271 -66.46%
2020 2.122.711 82.42%
2021 795.480 -166.85%
2022 -270.415 394.17%
2023 456.704 159.21%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cymat Technologies Ltd. Net Profit
Year Net Profit Growth
1997 -267.814
1998 -896.233 70.12%
1999 -1.648.488 45.63%
2000 -2.868.664 42.53%
2001 -7.048.989 59.3%
2002 -10.336.843 31.81%
2003 -8.433.451 -22.57%
2004 -5.763.196 -46.33%
2005 -5.781.877 0.32%
2006 -3.188.435 -81.34%
2007 -4.317.426 26.15%
2008 -4.605.534 6.26%
2009 -5.141.272 10.42%
2010 -4.051.908 -26.89%
2011 -4.785.014 15.32%
2012 443.440 1179.07%
2013 -1.824.381 124.31%
2014 -1.171.207 -55.77%
2015 -1.513.376 22.61%
2016 -1.043.920 -44.97%
2017 -1.116.178 6.47%
2018 -1.359.403 17.89%
2019 -1.814.977 25.1%
2020 -542.997 -234.25%
2021 -4.746.524 88.56%
2022 -6.047.793 21.52%
2023 -3.195.156 -89.28%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cymat Technologies Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 0
1998 -1 0%
1999 -1 100%
2000 -1 0%
2001 -2 50%
2002 -3 0%
2003 -2 0%
2004 -1 -100%
2005 -1 0%
2006 -1 0%
2007 -1 0%
2008 -1 0%
2009 -1 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cymat Technologies Ltd. Free Cashflow
Year Free Cashflow Growth
1997 -1.222.661
1998 -1.818.662 32.77%
1999 -1.601.134 -13.59%
2000 -3.517.803 54.48%
2001 -5.642.160 37.65%
2002 -8.978.770 37.16%
2003 -7.014.954 -27.99%
2004 -3.195.513 -119.53%
2005 -3.406.708 6.2%
2006 -2.516.200 -35.39%
2007 -1.788.576 -40.68%
2008 -2.442.974 26.79%
2009 -2.751.093 11.2%
2010 -2.689.966 -2.27%
2011 -738.612 -264.19%
2012 -1.118.336 33.95%
2013 -429.771 -160.22%
2014 -1.286.031 66.58%
2015 -596.274 -115.68%
2016 -372.612 -60.03%
2017 -836.802 55.47%
2018 -511.417 -63.62%
2019 -1.380.568 62.96%
2020 401.483 443.87%
2021 -4.532.811 108.86%
2022 -3.490.358 -29.87%
2023 97.814 3668.36%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cymat Technologies Ltd. Operating Cashflow
Year Operating Cashflow Growth
1997 156.657
1998 -1.161.695 113.49%
1999 -1.348.777 13.87%
2000 -2.594.215 48.01%
2001 -4.997.646 48.09%
2002 -8.069.880 38.07%
2003 -6.405.668 -25.98%
2004 -3.129.143 -104.71%
2005 -3.308.208 5.41%
2006 -2.429.512 -36.17%
2007 -1.785.668 -36.06%
2008 -2.427.933 26.45%
2009 -2.718.737 10.7%
2010 -2.583.986 -5.21%
2011 -710.610 -263.63%
2012 -1.118.336 36.46%
2013 -429.771 -160.22%
2014 -1.250.697 65.64%
2015 -517.286 -141.78%
2016 -362.464 -42.71%
2017 -763.484 52.53%
2018 -471.360 -61.97%
2019 -1.332.650 64.63%
2020 432.922 407.83%
2021 -4.318.072 110.03%
2022 -2.462.286 -75.37%
2023 97.814 2617.31%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cymat Technologies Ltd. Capital Expenditure
Year Capital Expenditure Growth
1997 1.379.318
1998 656.967 -109.95%
1999 252.357 -160.33%
2000 923.588 72.68%
2001 644.514 -43.3%
2002 908.890 29.09%
2003 609.286 -49.17%
2004 66.370 -818.01%
2005 98.500 32.62%
2006 86.688 -13.63%
2007 2.908 -2881.02%
2008 15.041 80.67%
2009 32.356 53.51%
2010 105.980 69.47%
2011 28.002 -278.47%
2012 0 0%
2013 0 0%
2014 35.334 100%
2015 78.988 55.27%
2016 10.148 -678.36%
2017 73.318 86.16%
2018 40.057 -83.03%
2019 47.918 16.41%
2020 31.439 -52.42%
2021 214.739 85.36%
2022 1.028.072 79.11%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cymat Technologies Ltd. Equity
Year Equity Growth
1997 -75.992
1998 975.667 107.79%
1999 3.832.794 74.54%
2000 20.371.679 81.19%
2001 29.494.596 30.93%
2002 27.551.558 -7.05%
2003 19.423.908 -41.84%
2004 16.327.050 -18.97%
2005 13.385.477 -21.98%
2006 11.375.866 -17.67%
2007 11.526.384 1.31%
2008 8.417.301 -36.94%
2009 7.621.609 -10.44%
2010 2.820.229 -170.25%
2011 -1.170.370 340.97%
2012 314.484 472.16%
2013 -1.481.608 121.23%
2014 -1.934.564 23.41%
2015 -3.290.304 41.2%
2016 -3.174.282 -3.66%
2017 95.356 3428.87%
2018 -943.141 110.11%
2019 -889.518 -6.03%
2020 2.875.882 130.93%
2021 2.342.602 -22.76%
2022 -612.074 482.73%
2023 -2.814.294 78.25%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cymat Technologies Ltd. Assets
Year Assets Growth
1997 1.888.013
1998 2.307.512 18.18%
1999 5.248.250 56.03%
2000 21.776.724 75.9%
2001 31.206.504 30.22%
2002 28.912.755 -7.93%
2003 20.188.818 -43.21%
2004 17.284.749 -16.8%
2005 14.196.139 -21.76%
2006 13.875.445 -2.31%
2007 12.365.329 -12.21%
2008 10.710.130 -15.45%
2009 9.290.680 -15.28%
2010 6.199.864 -49.85%
2011 1.519.831 -307.93%
2012 1.296.562 -17.22%
2013 814.159 -59.25%
2014 1.039.151 21.65%
2015 861.699 -20.59%
2016 996.002 13.48%
2017 1.690.580 41.09%
2018 735.341 -129.9%
2019 1.861.955 60.51%
2020 6.582.783 71.71%
2021 6.171.566 -6.66%
2022 4.156.098 -48.49%
2023 3.961.743 -4.91%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cymat Technologies Ltd. Liabilities
Year Liabilities Growth
1997 1.964.005
1998 1.331.845 -47.46%
1999 1.415.456 5.91%
2000 1.405.045 -0.74%
2001 1.711.908 17.93%
2002 1.361.197 -25.76%
2003 764.910 -77.96%
2004 957.699 20.13%
2005 810.662 -18.14%
2006 2.499.579 67.57%
2007 838.945 -197.94%
2008 2.292.829 63.41%
2009 1.669.071 -37.37%
2010 3.379.635 50.61%
2011 2.690.201 -25.63%
2012 982.078 -173.93%
2013 2.295.767 57.22%
2014 2.973.715 22.8%
2015 4.152.003 28.38%
2016 4.170.284 0.44%
2017 1.595.224 -161.42%
2018 1.678.482 4.96%
2019 2.751.473 39%
2020 3.706.901 25.77%
2021 3.828.964 3.19%
2022 4.768.172 19.7%
2023 6.776.037 29.63%

Cymat Technologies Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.02
Net Income per Share
-0.06
Price to Earning Ratio
-1.85x
Price To Sales Ratio
4.87x
POCF Ratio
-3.53
PFCF Ratio
-3.49
Price to Book Ratio
-2.8
EV to Sales
7.07
EV Over EBITDA
-3.43
EV to Operating CashFlow
-5.13
EV to FreeCashFlow
-5.06
Earnings Yield
-0.54
FreeCashFlow Yield
-0.29
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.25
Graham NetNet
-0.09

Income Statement Metrics

Net Income per Share
-0.06
Income Quality
0.52
ROE
2.35
Return On Assets
-1.08
Return On Capital Employed
6.69
Net Income per EBT
1
EBT Per Ebit
1.11
Ebit per Revenue
-2.38
Effective Tax Rate
-0.04

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.1
Stock Based Compensation to Revenue
0.22
Gross Profit Margin
-0.28
Operating Profit Margin
-2.38
Pretax Profit Margin
-2.63
Net Profit Margin
-2.63

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.03
Free CashFlow per Share
-0.03
Capex to Operating CashFlow
-0.01
Capex to Revenue
0.02
Capex to Depreciation
0.06
Return on Invested Capital
5.55
Return on Tangible Assets
-1.08
Days Sales Outstanding
41.53
Days Payables Outstanding
283.65
Days of Inventory on Hand
214.86
Receivables Turnover
8.79
Payables Turnover
1.29
Inventory Turnover
1.7
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,04
Tangible Book Value per Share
-0.04
Shareholders Equity per Share
-0.04
Interest Debt per Share
0.04
Debt to Equity
-0.74
Debt to Assets
0.53
Net Debt to EBITDA
-1.07
Current Ratio
0.35
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-604378
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
921999
Debt to Market Cap
0.27

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cymat Technologies Ltd. Dividends
Year Dividends Growth

Cymat Technologies Ltd. Profile

About Cymat Technologies Ltd.

Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. The company provides architectural materials under the Alusion brand name; and automotive and blast mitigation products under the SmartMetal brand name. It serves defense and military, automotive and transportation, architectural, and other application. The company was incorporated in 2006 and is based in Mississauga, Canada.

CEO
Mr. Michael M. Liik MBA, P. En
Employee
11
Address
6320-2 Danville Road
Mississauga, L5T 2L7

Cymat Technologies Ltd. Executives & BODs

Cymat Technologies Ltd. Executives & BODs
# Name Age
1 Mr. Michael M. Liik MBA, P. Eng, P.Eng.
Executive Chairman & Chief Executive Officer
70
2 Mr. Darryl Gregory Kleebaum
Chief Financial Officer
70
3 Mr. Mario DeAngelis
Chief Operating Officer
70
4 Mr. Vince Benincasa
Chief Commercial Officer
70
5 Mr. David Henry
Head of U.S. Business Development
70

Cymat Technologies Ltd. Competitors